Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant 13vPnC and Influenza Vaccine in Adults 50+
NCT02124161Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2014
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in invasive pneumococcal disease (IPD), sponsored by Pfizer. Started Sep 2014; status: completed.
02
Drugs
Prevnar 13
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on NCT02124161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124161.